Human vaccines & immunotherapeutics

The most recent articles from: Hum Vaccin Immunother June 2016

Hum Vaccin Immunother · Jun 2016

Editorial

HPV vaccination: Clinical potential, implementation challenges, and future directions.

no abstract available

keep going… or not…
Hum Vaccin Immunother · Jun 2016

Comparative Study

The impact and cost-effectiveness of nonavalent HPV vaccination in the United States: Estimates from a simplified transmission model.

The objective of this study was to assess the incremental costs and benefits of the 9-valent HPV vaccine (9vHPV) compared with the quadrivalent HPV vaccine (4vHPV). Like 4vHPV, 9vHPV protects against HPV types 6, 11, 16, and 18. 9vHPV also protects against 5 additional HPV types 31, 33, 45, 52, and 58. ⋯ Compared with a vaccination program of 4vHPV for both sexes, a vaccination program of 9vHPV for both sexes can improve health outcomes and can be cost-saving.

read on… or not…

Want more great medical articles?

Keep up to date with a free trial of metajournal, personalized for your practice.
1,694,794 articles already indexed!